211315-24-1

Usage

Uses

Used in Organic Synthesis:
[4-(dibenzylamino)phenyl]acetonitrile is utilized as a building block in organic synthesis, contributing to the creation of diverse chemical compounds.
Used in Pharmaceutical Development:
As a precursor for the synthesis of various pharmaceuticals, [4-(dibenzylamino)phenyl]acetonitrile plays a significant role in the development of new drugs, making it a valuable asset in the medicinal chemistry field.
Used in Agrochemical Synthesis:
[4-(dibenzylamino)phenyl]acetonitrile is also employed as a precursor in the synthesis of agrochemicals, further expanding its applications across different industries.

Upstream product

• 3544-25-0 p-aminophenylacetonitrile 
• 100-39-0 benzyl bromide 

Downstream Products

• 329188-34-3 2-(4-(N,N-dibenzylamino)phenyl)propylamine hydrochloride 
• 211315-25-2 2-(4-(N,N-dibenzylamino)phenyl)propionitrile 

Relevant academic research and scientific papers

N-2-(4-N-(4-[18F]Fluorobenzamido)phenyl)-propyl-2- propanesulphonamide: Synthesis and radiofluorination of a putative AMPA receptor ligand

Arylpropylsulphonamides are in the focus of research as α-amino-3-hydroxy-5-methyl-4-isoxazolpropionic acid (AMPA) receptor ligands. A new fluorine-18-labelled potentiator of AMPA receptors was synthesized as a potential radiotracer for cerebral imaging w

Sulphonamide derivatives

Glutamate receptor function in a mammal may be potentiated using an effective amount of a compound of formulaR1—L—NHSO2R2??Iin whichR1 represents an unsubstituted or substituted aromatic or heteroaromatic group;R2 represents (1-6C)alkyl, (3-6C)cycloalkyl, (1-6C)fluoroalkyl, (1-6C)chloroalkyl, (2-6C)alkenyl, (1-4C)alkoxy(1-4C)alkyl, phenyl which is unsubstituted or substituted by halogen, (1-4C)alkyl or (1-4C)alkoxy, or a group, of formula R3R4N in which R3 and R4 each independently represents (1-4C)alkyl or, together with the nitrogen atom to which they are attached form an azetidinyl, pyrrolidinyl, piperidinyl, morpholino, piperazinyl, hexahydroazepinyl or octahydroazocinyl group; andL represents a (2-4C)alkylene chain which is unsubstituted or substituted by one or two substituents selected independently from (1-6C)alkyl, aryl(1-6C)alkyl, (2-6C)alkenyl, aryl(2-6C)alkenyl and aryl, or by two substituents which, together with the carbon atom or carbon atoms to which they are attached form a (3-8C)carbocyclic ring;and pharmaceutically acceptable salts thereof.Also disclosed are compounds of formula I, processes for preparing them and pharmaceutical compositions containing them.